FR11C0040I2 - METHOD FOR IN VITRO CULTURE OF DIFFERENT STAGES OF TISSUE PARASITES - Google Patents

METHOD FOR IN VITRO CULTURE OF DIFFERENT STAGES OF TISSUE PARASITES

Info

Publication number
FR11C0040I2
FR11C0040I2 FR11C0040C FR11C0040C FR11C0040I2 FR 11C0040 I2 FR11C0040 I2 FR 11C0040I2 FR 11C0040 C FR11C0040 C FR 11C0040C FR 11C0040 C FR11C0040 C FR 11C0040C FR 11C0040 I2 FR11C0040 I2 FR 11C0040I2
Authority
FR
France
Prior art keywords
different stages
vitro culture
tissue parasites
parasites
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR11C0040C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Recherche pour le Developpement IRD
Original Assignee
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut de Recherche pour le Developpement IRD filed Critical Institut de Recherche pour le Developpement IRD
Publication of FR11C0040I1 publication Critical patent/FR11C0040I1/fr
Application granted granted Critical
Publication of FR11C0040I2 publication Critical patent/FR11C0040I2/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FR11C0040C 1993-05-13 2011-09-13 METHOD FOR IN VITRO CULTURE OF DIFFERENT STAGES OF TISSUE PARASITES Active FR11C0040I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9305779A FR2705358B1 (en) 1993-05-13 1993-05-13 Method of in vitro culture of different stages of tissue parasites, parasitic stages obtained and biological applications.
PCT/FR1994/000577 WO1994026899A1 (en) 1993-05-13 1994-05-13 Method for the culture in vitro of differents stages of tissue parasites

Publications (2)

Publication Number Publication Date
FR11C0040I1 FR11C0040I1 (en) 2011-10-14
FR11C0040I2 true FR11C0040I2 (en) 2012-06-22

Family

ID=9447092

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9305779A Expired - Lifetime FR2705358B1 (en) 1993-05-13 1993-05-13 Method of in vitro culture of different stages of tissue parasites, parasitic stages obtained and biological applications.
FR11C0040C Active FR11C0040I2 (en) 1993-05-13 2011-09-13 METHOD FOR IN VITRO CULTURE OF DIFFERENT STAGES OF TISSUE PARASITES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9305779A Expired - Lifetime FR2705358B1 (en) 1993-05-13 1993-05-13 Method of in vitro culture of different stages of tissue parasites, parasitic stages obtained and biological applications.

Country Status (8)

Country Link
US (4) US6458581B1 (en)
EP (1) EP0698099B1 (en)
AU (1) AU6800094A (en)
CA (1) CA2162555C (en)
DE (2) DE69434424T2 (en)
ES (1) ES2245776T3 (en)
FR (2) FR2705358B1 (en)
WO (1) WO1994026899A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9503451A (en) * 1995-07-26 1997-09-30 Mendes Rodolfo Pereira Process of preparation of an antigen derived from a microorganism that causes infectious and / or parasitic disease Process of preparation of an antigen from T cruzi antigen derived from a microorganism that causes infectious disease and / or parasitic antigen derived from T cruzi that causes Chagas disease composition the base of an antigen derived from microorganism that causes infectious and / or parasitic disease composition the base of antigen from T cruzi use of the antigen derived from microorganism that causes infectious and / or parasitic disease in serological tests and vaccines use of antigen derived from T cruzi cause of chagas disease in serological tests and vaccines process for detecting antibodies against microorganism antigen causing infectious and / or parasitic disease and confirmatory serodiagnosis kit for infectious and / or parasitic disease
FR2825633B1 (en) * 2001-06-11 2005-12-16 Bio Veto Tests Bvt THERAPEUTIC VACCINE COMPLEX FOR THE PREVENTION AND TREATMENT OF LEISHMANIOSES AND INTRACELLULAR PATHOGENIC MICROORGANISM INFECTIONS IN MAMMALS
FR2863272B1 (en) * 2003-11-19 2006-06-09 Inst Rech Developpement Ird NEW MEANS FOR THE PREVENTION OF LEISHMANIOSES
FR2862313B1 (en) * 2003-11-19 2006-02-24 Inst Rech Developpement Ird NEW MEANS FOR THE PREVENTION OF LEISHMANIOSES
US20050176144A1 (en) * 2004-02-06 2005-08-11 O'daly Jose A. Culture media compositions free of fetal bovine serum
FR2881752B1 (en) 2005-02-10 2009-07-31 Inst Rech Pour Le Dev I R D Et MEANS FOR OBTAINING PROMASTIGOTS OF AVIRULENT, PROMASTIGIOUS LEISHANIES OBTAINED AND THEIR APPLICATIONS
DE102006041388A1 (en) * 2006-08-29 2008-03-20 Fachhochschule Jena Nutrient medium for culturing protozoa comprises yeast extract, phosphate, hemin and glucose
FR3014103B1 (en) 2013-11-29 2019-08-16 Institut De Recherche Pour Le Developpement (Ird) VACCINE COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF LEISHMANIOSES, IMMUNOGENIC PEPTIDES AND METHOD OF OBTAINING
FR3081870A1 (en) 2018-05-30 2019-12-06 Institut De Recherche Pour Le Developpement (Ird) EPITOPES, MONO- OR MULTIEPITOPIC PEPTIDE COMPOUNDS AND LEISHMANIA VACCINES
WO2020041849A1 (en) 2018-08-31 2020-03-05 Fundação Oswaldo Cruz Method for detecting antibodies against leishmania in a canine biological sample, kit for detecting infection with leishmania in a biological sample, and use of lipophosphoglycan of leishmania

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US399743A (en) * 1889-03-19 Peters
FR1518449A (en) * 1967-04-12 1968-03-22 Vnii Antibiotikov Leishmania culture process
US3993743A (en) * 1973-08-07 1976-11-23 Research Corporation Method for diagnosis of Chagas' disease
US3911097A (en) * 1973-08-07 1975-10-07 Research Corp Antigenic preparation suitable for diagnosis of chronic chagas disease
IL67295A0 (en) * 1981-11-17 1983-03-31 Brigham & Womens Hospital Monoclonal antibodies against leishmania
US4992273A (en) * 1984-10-01 1991-02-12 Institut Pasteur Antigens of Leishmania parasites
US4687666A (en) * 1985-02-19 1987-08-18 Ministerio De Sanidad Y Asistencia Social Instituto Venezolano De Investigationes Cientificas Vaccine for Leishmaniasis
GB8921937D0 (en) * 1989-09-28 1989-11-15 Howard Michael K Diagnostic reagents for leishmaniasis
WO1993003167A1 (en) * 1991-08-06 1993-02-18 The World Health Organisation Method of isolation of dna
US5411865A (en) * 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies

Also Published As

Publication number Publication date
FR2705358B1 (en) 1995-08-04
ES2245776T3 (en) 2006-01-16
DE122011100046I1 (en) 2012-01-19
CA2162555C (en) 2011-07-12
US20030068690A1 (en) 2003-04-10
CA2162555A1 (en) 1994-11-24
AU6800094A (en) 1994-12-12
US20030059860A1 (en) 2003-03-27
US6458581B1 (en) 2002-10-01
US7282210B2 (en) 2007-10-16
US20030138461A1 (en) 2003-07-24
WO1994026899A1 (en) 1994-11-24
DE69434424D1 (en) 2005-08-18
FR2705358A1 (en) 1994-11-25
US7317094B2 (en) 2008-01-08
FR11C0040I1 (en) 2011-10-14
DE69434424T2 (en) 2006-04-20
EP0698099A1 (en) 1996-02-28
EP0698099B1 (en) 2005-07-13

Similar Documents

Publication Publication Date Title
FR11C0040I2 (en) METHOD FOR IN VITRO CULTURE OF DIFFERENT STAGES OF TISSUE PARASITES
BR9608638A (en) Pharmaceutical process and composition for the selective treatment of cell and compound growth and differentiation
FI905228A0 (en) Method for inhibiting the growth and multiplication of microorganisms
DE59410356D1 (en) DEVICE FOR THERMAL DEODILATION OF BIOLOGICAL TISSUE
DK0690873T3 (en) Growth Differentiation Factor-8
EP0861586A4 (en) Support for plant culture and method for plant growth
EP0691400A4 (en) Process for embedding culture of animal cells
FI932031A (en) System and method of production For the purpose of biological control
IT1207525B (en) METHOD FOR THE PRESERVATION OF TRANSPLANTABLE SHEETS OF EPITELIUM CULTIVATED IN VITRO VITRO.
FR2742126B1 (en) DEPALETTIZATION PROCESS AND RESULTING PALETTE
AR241936A1 (en) Method for cultivation of bacteria
NO923684D0 (en) PROCEDURE FOR AA LIMIT DOWNLOADED GROWTH IN INDUCED HYDRAULIC FRACTURES
FR2607266B1 (en) OBJECTIVE FOR AN ENDOSCOPE AND METHOD FOR ITS MANUFACTURE
BR9000838A (en) PROCESS FOR THE DESICTION AND ABCISATION OF PLANT ORGANS
AU4862397A (en) Method for optic detection and treatment of cultivated plants and non biologically transformed cultivated plants
IT1240837B (en) PROCEDURE AND PLANT FOR BIOLOGICAL WASTEWATER TREATMENT
BR9003442A (en) PLANT EMBRYO CONSERVATION PROCESS AND ARTIFICIAL SEED
DE69528051D1 (en) CRYSTAL GROWTH PROCESS
FR2663039B1 (en) PROCESS AND INSTALLATION FOR CULTURE OF ANAEROBIC GERM.
ITTO930410A1 (en) PROCESS AND PLANT FOR THE PROCESSING OF WASTE
FR2646989B1 (en) ALGAE CULTURE BASIN AND METHOD OF IMPLEMENTING SAME
AU6153094A (en) Plant tissue culture method for taxol production
IL97995A0 (en) Method of inducing embryogenesis of plant cells
PT86597A (en) PROCEDE DE RECONSTITUITION IN VITRO DE TISSUS
ZA901280B (en) Tissue culture method